Detected ·
iORGANBIO
—Other
iORGANBIO, a U.S.-based biotech developing a human cell and organoid design/manufacturing platform, received a new investment from Mitsui Chemicals Group to advance drug discovery, cell therapy, and regenerative medicine solutions.
- Website
- iorgan.bio
- linkedin.com/company/107422952
- Amount
- —
- Stage
- Other
- Event
- Funding round
- Detected
- 2026-10-30 20:18:50 UTC
- Signal ID
- c8a5d68a-ad05-4c26-9a32-0fd306431de8
As the API returns it
{
"id": "c8a5d68a-ad05-4c26-9a32-0fd306431de8",
"created_at": "2026-10-30T20:18:50.721356Z",
"company_name": "iORGANBIO",
"company_website_url": "iorgan.bio",
"company_linkedin_url": "https://www.linkedin.com/company/107422952",
"event_type": "funding",
"funding_amount": null,
"funding_currency": null,
"funding_stage": "other",
"message": "*iORGANBIO, a U.S.-based biotech developing a human cell and organoid design/manufacturing platform, received a new investment from Mitsui Chemicals Group to advance drug discovery, cell therapy, and regenerative medicine solutions.*"
}